Published 20 June 2005. doi:10.1084/jem.20041484
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 12, 1949-1960
Combined loss of proapoptotic genes Bak or Bax with Bim synergizes to cause defects in hematopoiesis and in thymocyte apoptosis
Jack Hutcheson1,
John C. Scatizzi1,
Emily Bickel1,
Nathaniel J. Brown1,
Philippe Bouillet2,
Andreas Strasser2, and
Harris Perlman1
1 Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO 63104
2 The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3050, Australia
CORRESPONDENCE Harris Perlman: perlmanh{at}slu.edu
The proapoptotic members of the Bcl-2 family can be subdivided into members that contain several Bcl-2 homology (BH) domains and those that contain only the BH3 domain. Although it is known that BH3-only proteins and the multi-BH domain proteins, Bak and Bax, are essential for programmed cell death, the overlapping role of these two subgroups has not been examined in vivo. To investigate this, we generated Bak/Bim and Bax/Bim double deficient mice. We found that although Bax/Bim/, but not Bak/Bim/, mice display webbed hind and front paws and malocclusion of the incisors, both groups of mice present with dysregulated hematopoiesis. Combined loss of Bak and Bim or Bax and Bim causes defects in myeloid and B-lymphoid development that are more severe than those found in the single knock-out mice. Bak/Bim/ mice have a complement of thymocytes that resembles those in control mice, whereas Bax/Bim/ mice are more similar to Bim/ mice. However, thymocytes isolated from Bak/Bim/ or Bax/Bim/ mice are markedly more resistant to apoptotic stimuli mediated by the intrinsic pathway as compared with thymocytes from single-knockout mice. These data suggest an essential overlapping role for Bak or Bax and Bim in the intrinsic apoptotic pathway.
Abbreviations: 7-AAD, 7-aminoactinomycin D; BH, Bcl-2 homology; DKO, double KO; ES, embryonic stem.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Okumura, K., Huang, S., Sinicrope, F. A.
(2008). Induction of Noxa Sensitizes Human Colorectal Cancer Cells Expressing Mcl-1 to the Small-Molecule Bcl-2/Bcl-xL Inhibitor, ABT-737. Clin. Cancer Res.
14: 8132-8142
[Abstract]
[Full Text]
-
Demoulins, T., Abdallah, A., Kettaf, N., Baron, M.-L., Gerarduzzi, C., Gauchat, D., Gratton, S., Sekaly, R.-P.
(2008). Reversible Blockade of Thymic Output: An Inherent Part of TLR Ligand-Mediated Immune Response. J. Immunol.
181: 6757-6769
[Abstract]
[Full Text]
-
Huang, S., Sinicrope, F. A.
(2008). BH3 Mimetic ABT-737 Potentiates TRAIL-Mediated Apoptotic Signaling by Unsequestering Bim and Bak in Human Pancreatic Cancer Cells. Cancer Res.
68: 2944-2951
[Abstract]
[Full Text]
-
Doonan, F., Donovan, M., Gomez-Vicente, V., Bouillet, P., Cotter, T. G.
(2007). Bim Expression Indicates the Pathway to Retinal Cell Death in Development and Degeneration. J. Neurosci.
27: 10887-10894
[Abstract]
[Full Text]
-
Diwan, A., Koesters, A. G., Odley, A. M., Pushkaran, S., Baines, C. P., Spike, B. T., Daria, D., Jegga, A. G., Geiger, H., Aronow, B. J., Molkentin, J. D., Macleod, K. F., Kalfa, T. A., Dorn, G. W. II
(2007). Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis. Proc. Natl. Acad. Sci. USA
104: 6794-6799
[Abstract]
[Full Text]
-
Dansen, T. B., Whitfield, J., Rostker, F., Brown-Swigart, L., Evan, G. I.
(2006). Specific Requirement for Bax, Not Bak, in Myc-induced Apoptosis and Tumor Suppression in Vivo. J. Biol. Chem.
281: 10890-10895
[Abstract]
[Full Text]
-
Han, J., Goldstein, L. A., Gastman, B. R., Rabinowich, H.
(2006). Interrelated Roles for Mcl-1 and BIM in Regulation of TRAIL-mediated Mitochondrial Apoptosis. J. Biol. Chem.
281: 10153-10163
[Abstract]
[Full Text]
-
Liu, H., Eksarko, P., Temkin, V., Haines, G. K. III, Perlman, H., Koch, A. E., Thimmapaya, B., Pope, R. M.
(2005). Mcl-1 Is Essential for the Survival of Synovial Fibroblasts in Rheumatoid Arthritis. J. Immunol.
175: 8337-8345
[Abstract]
[Full Text]